![[Article Title]](https://media.americanpharmaceuticalreview.com/m/28/article/619289-134x100.jpg)
Advanced Therapy Medicinal Products (ATMPs), including cell therapies, gene therapies, and tissue-engineered products are transformative - targeting rare genetic disorders, cancers, and chronic conditions with personalized approaches. The integration of artificial intelligence (AI) is revolutionizing ATMP development by accelerating the identification of biomarkers, optimizing therapeutic vector design, and enabling personalized medicine by predicting individual patient responses to therapy.
This infographic explores the ATMP market landscape, key challenges in potency assay development, and solutions to overcome those challenges. Download now to learn more.